Bottom line
RYSGX vs XSMO: the short answer
RYSGX (S&P SmallCap 600 Pure Growth Fund) and XSMO (Invesco S&P SmallCap Momentum ETF) are both mutual funds.
XSMO is cheaper at 0.35% vs 1.53% — a difference of $118 a year per $10,000 invested.
Over five years, XSMO returned +9.6% a year vs +1.9% for RYSGX.
RYSGX has a front-end sales load of up to 4.75%; the other does not.
Updated Nov 19, 2026
RYSGX vs XSMO side by side
| RYSGX | XSMO | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Guggenheim | Invesco |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 1.53% | 0.35% |
| Annual cost per $10k | $153 | $35 |
| 10-yr cost on $10k (prospectus) | $2,260 | $444 |
| Max front load | 4.75% | None |
| 12b-1 fee | 0.25% | — |
| 1-yr return | +3.4% | +9.8% |
| 5-yr return (annualized) | +1.9% | +9.6% |
| 10-yr return (annualized) | +6.1% | +12.3% |
| Best quarter | — | +23.7% |
| Worst quarter | — | −25.2% |
| Net assets (fund) | $60.7M | $3.0B |
| Number of holdings | 129 | 110 |
| Portfolio turnover | 1,133% | 121% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
9 of RYSGX's top 25 holdings also appear in XSMO's top 25.
| Holding | RYSGX | XSMO |
|---|---|---|
| Acm Research Inc | 3.80% | 1.78% |
| Powell Industries Inc | 2.05% | 1.76% |
| Stonex Group Inc | 1.66% | 2.17% |
| Protagonist Therapeutics Inc | 1.59% | 2.57% |
| Myr Group Inc | 1.48% | 1.59% |
| Enova International Inc | 1.47% | 1.52% |
| Ptc Therapeutics Inc | 1.41% | 1.43% |
| Viasat Inc | 1.37% | 4.59% |
| Ligand Pharmaceuticals Inc | 1.23% | 1.88% |
Source: SEC Form N-PORT
RYSGX top 10
- Acm Research Inc — 3.80%
- Powell Industries Inc — 2.05%
- Argan Inc — 2.04%
- Dave Inc — 1.85%
- Stonex Group Inc — 1.66%
- Protagonist Therapeutics Inc — 1.59%
- Sphere Entertainment Company — 1.56%
- Clear Secure Inc — 1.54%
- Alignment Healthcare Inc — 1.53%
- Liquidia Corp — 1.51%
XSMO top 10
- Invesco Private Prime Fund — 11.81%
- Viasat, Inc. — 4.59%
- Invesco Private Government Fund — 4.51%
- ESCO Technologies Inc. — 2.97%
- Protagonist Therapeutics, Inc. — 2.57%
- Indivior Pharmaceuticals, Inc. — 2.20%
- Mercury Systems, Inc. — 2.17%
- StoneX Group Inc. — 2.17%
- FormFactor, Inc. — 1.98%
- Ligand Pharmaceuticals Inc. — 1.88%
FAQ
What is the difference between RYSGX and XSMO?
Which is cheaper, RYSGX or XSMO?
Should I own both RYSGX and XSMO?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.